Dr. Gentzler received his MD degree from Temple University School of Medicine and completed his Internal Medicine internship and residency at Thomas Jefferson University Hospital. He earned a master’s degree in pharmacology during his residency with a focus on clinical investigation supported by the NIH K30 program. He completed his hematology/oncology fellowship at Northwestern University, where he served as a chief fellow in his final year of fellowship. He also attended the ASCO/AACR Workshop for Methods in Clinical Cancer Research, where he advanced his knowledge of early phase clinical trial development and wrote a protocol for a Phase I/II investigator-initiated trial for patients with lung cancer.

Gentzler’s clinical focus is the treatment of patients with lung cancer and other thoracic malignancies. He also treats patients with esophageal cancer and cancers of the head and neck. His research is centered around the development of novel therapies for lung cancer, particularly immune-based therapies. His goal is to contribute meaningful research that leads to improvements in the curability, survival, and quality of life for patients with lung cancer. He serves as the principle investigator on several clinical trials and is actively working to open additional trials for patients at the University of Virginia.

Read 5 Common Lung Cancer Beliefs: True or False?, a blog post by Ryan Gentzler, MD.

Related Media:

NBC29 House Call - Dr. Ryan Gentzler on Lung Cancer

Emmanuel M. Weinberger Award: Outstanding Achievement in Hematology/Oncology, Temple University School of Medicine , 2008

Kowlessar Award: Graduating Resident who demonstrates commitment to excellence in practice of internal medicine, education, and compassion. Thomas Jefferson University Hospital, 2011

Excellence in Teaching Award, Department of Medicine, Northwestern University Feinberg School of Medicine, 2013

Compassionate Care Award, Women’s Board, Northwestern University, 2014